123 related articles for article (PubMed ID: 25591474)
21. Pharmacology of calcineurin antagonists.
Kapturczak MH; Meier-Kriesche HU; Kaplan B
Transplant Proc; 2004 Mar; 36(2 Suppl):25S-32S. PubMed ID: 15041303
[TBL] [Abstract][Full Text] [Related]
22. Chlorpyrifos and malathion have opposite effects on behaviors and brain size that are not correlated to changes in AChE activity.
Richendrfer H; Creton R
Neurotoxicology; 2015 Jul; 49():50-8. PubMed ID: 25983063
[TBL] [Abstract][Full Text] [Related]
23. [Multiple actions of tacrolimus and cyclosporin A as specific inhibitors of calcineurin].
Tamura K
Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1118-30. PubMed ID: 9655970
[No Abstract] [Full Text] [Related]
24. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
[TBL] [Abstract][Full Text] [Related]
25. Correlation between pharmacological efficacy of cyclosporine A and tacrolimus, evaluated by lymphocyte immunosuppressant-sensitivity test (LIST) with MTT assay procedure in renal transplant recipients.
Sugiyama K; Arakawa K; Satoh H; Saito K; Takahashi K; Saito N; Hirano T
J Immunoassay Immunochem; 2006; 27(2):195-205. PubMed ID: 16711256
[TBL] [Abstract][Full Text] [Related]
26. The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats.
Tsukamoto T; Iyo M; Tani K; Sekine Y; Hashimoto K; Ohashi Y; Suzuki K; Iwata Y; Mori N
Psychopharmacology (Berl); 2001 Nov; 158(2):107-13. PubMed ID: 11702083
[TBL] [Abstract][Full Text] [Related]
27. The safety of calcineurin inhibitors for kidney-transplant patients.
Malvezzi P; Rostaing L
Expert Opin Drug Saf; 2015 Oct; 14(10):1531-46. PubMed ID: 26329325
[TBL] [Abstract][Full Text] [Related]
28. Immunosuppressant calcineurin inhibitors phase shift circadian rhythms and inhibit circadian responses to light.
Katz ME; Simonetta SH; Ralph MR; Golombek DA
Pharmacol Biochem Behav; 2008 Oct; 90(4):763-8. PubMed ID: 18590756
[TBL] [Abstract][Full Text] [Related]
29. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
Weir MR; Ward MT; Blahut SA; Klassen DK; Cangro CB; Bartlett ST; Fink JC
Kidney Int; 2001 Apr; 59(4):1567-73. PubMed ID: 11260422
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of cyclosporine and tacrolimus on mycophenolate pharmacokinetics in patients with impaired kidney function.
Hohage H; Zeh M; Heck M; Gerhardt UW; Welling U; Suwelack BM
Transplant Proc; 2005 May; 37(4):1748-50. PubMed ID: 15919453
[TBL] [Abstract][Full Text] [Related]
31. Different effects of neuroprotectants FK-506 and cyclosporin A on susceptibility to pilocarpine-induced seizures in rats with brain injured at different developmental stages.
Setkowicz Z; Ciarach M; Guzik R; Janeczko K
Epilepsy Res; 2004; 61(1-3):63-72. PubMed ID: 15451009
[TBL] [Abstract][Full Text] [Related]
32. A role for calcineurin in Dictyostelium discoideum development.
Horn F; Gross J
Differentiation; 1996 Sep; 60(5):269-75. PubMed ID: 8855370
[TBL] [Abstract][Full Text] [Related]
33. Activation of the dual-leucine-zipper-bearing kinase and induction of beta-cell apoptosis by the immunosuppressive drug cyclosporin A.
Plaumann S; Blume R; Börchers S; Steinfelder HJ; Knepel W; Oetjen E
Mol Pharmacol; 2008 Mar; 73(3):652-9. PubMed ID: 18042735
[TBL] [Abstract][Full Text] [Related]
34. Cluster analysis profiling of behaviors in zebrafish larvae treated with antidepressants and pesticides.
Richendrfer H; Creton R
Neurotoxicol Teratol; 2018; 69():54-62. PubMed ID: 29101052
[TBL] [Abstract][Full Text] [Related]
35. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.
Sharkey J; Butcher SP
Nature; 1994 Sep; 371(6495):336-9. PubMed ID: 7522303
[TBL] [Abstract][Full Text] [Related]
36. Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation.
Hernández-Espinosa D; Morton AJ
Brain Res Bull; 2006 May; 69(6):669-79. PubMed ID: 16716837
[TBL] [Abstract][Full Text] [Related]
37. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus.
Lee JT; Whitson BA; Kelly RF; D'Cunha J; Dunitz JM; Hertz MI; Shumway SJ
J Surg Res; 2013 Sep; 184(1):599-604. PubMed ID: 23566442
[TBL] [Abstract][Full Text] [Related]
38. Effect of different immunosuppressive drugs on immune cells from young and old healthy persons.
Welzl K; Kern G; Mayer G; Weinberger B; Säemann MD; Sturm G; Grubeck-Loebenstein B; Koppelstaetter C
Gerontology; 2014; 60(3):229-38. PubMed ID: 24434865
[TBL] [Abstract][Full Text] [Related]
39. Relationship between pharmacokinetics and pharmacodynamics of calcineurin inhibitors in renal transplant patients.
Albring A; Wendt L; Harz N; Engler H; Wilde B; Kribben A; Lindemann M; Schedlowski M; Witzke O
Clin Transplant; 2015 Apr; 29(4):294-300. PubMed ID: 25557538
[TBL] [Abstract][Full Text] [Related]
40. FK506 induces endothelial dysfunction through attenuation of Akt and ERK1/2 independently of calcineurin inhibition and the caspase pathway.
Eguchi R; Kubo S; Ohta T; Kunimasa K; Okada M; Tamaki H; Kaji K; Wakabayashi I; Fujimori Y; Ogawa H
Cell Signal; 2013 Sep; 25(9):1731-8. PubMed ID: 23707520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
